Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk

被引:96
作者
Reed, AB
Gaccione, P
Belkin, M
Donaldson, MC
Mannick, A
Whittemore, AD
Conte, MS
机构
[1] Brigham & Womens Hosp, Div Vasc Surg, Boston, MA 02115 USA
[2] Univ Cincinnati, Ctr Med, Div Vasc Surg, Cincinnati, OH USA
关键词
D O I
10.1016/S0741-5214(03)00336-7
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: The efficacy of carotid endarterectomy (CEA) for prevention of stroke has been demonstrated in randomized trials; however, the optimal approach in patients excluded from these trials or who have other significant comorbid conditions remains controversial, particularly with the advent of percutaneous interventions. We examined the influence of putative risk factors on outcome of CEA in a single-center experience. Methods: A retrospective analysis of 1370 consecutive CEA performed from 1990 to 1999 was undertaken. Preoperative risk factors examined included age older than 80 years, congestive heart failure, chronic obstructive pulmonary disease, renal failure (serum creatinine concentration > 2.0 mg/dL), contralateral carotid artery occlusion, recurrent ipsilateral carotid artery stenosis, ipsilateral hemispheric symptoms within 6 weeks, and recent coronary bypass grafting (CABG). The Fisher exact test was used to identify baseline variables associated with perioperative (30 days) risk for stroke or death. Multivariate analysis with Poisson regression was used to study the effect of all univariate criteria in combination. Results. In the overall cohort, there were 32 adverse events (2.3%), including 11 deaths (0.8%), 6 disabling strokes (0.4%), and 10 nondisabling strokes (0.7%). There was no significant difference in incidence of perioperative stroke or death between patients with one or more risk factors (n = 689) and those with no risk factors (low risk, n = 681). Thirty-day mortality was significantly greater in patients with two or more risk factors compared with patients with no risk factors (2.8% vs 0.3%; P = .04), but no significant difference was noted in perioperative stroke rate (2.3% vs 1.0%). Univariate analysis demonstrated that contralateral carotid occlusion (n = 75) was the only significant predictor of adverse outcome (5 events, 6.7%) among the variables tested; this was confirmed with multivariate analysis (relative risk, 4.3; 95% confidence interval, 1.2-12.3; P = .01). Five-year survival for patients with two or more risk factors was notably diminished compared with that for patients with no risk factors (38.7% +/- 5.9% vs 75.0% +/- 2.6%; P <.001). Contralateral occlusion was also associated with reduced 5-year survival (38 +/- 11% vs 67 2%; P <.004). Conclusion: CEA can be safely performed in patients deemed at high risk, including those aged 80 years or older and others with significant comorbid conditions, with combined stroke and mortality rates comparable to those found in randomized trials, ie, the Asymptomatic Carotid Atherosclerosis Study and the North American Symptomatic Carotid Endarterectomy Trial. Contralateral occlusion may be a predictor for moderately increased perioperative risk and for reduced long-term survival. Caution may be warranted in asymptomatic patients with multiple risk factors, in whom presumed long-term benefit of CEA may be compromised by markedly reduced 5-year survival. (J Vasc Surg 2003;37: 1191-9.).
引用
收藏
页码:1191 / 1199
页数:9
相关论文
共 17 条
[1]  
Adelman M A, 1995, Cardiovasc Surg, V3, P307, DOI 10.1016/0967-2109(95)93881-O
[2]   Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis [J].
Alamowitch, S ;
Eliasziw, M ;
Algra, A ;
Meldrum, H ;
Barnett, HJM .
LANCET, 2001, 357 (9263) :1154-1160
[3]  
Baker J D, 1988, J Vasc Surg, V8, P721
[4]   Effect of contralateral occlusion on long-term efficacy of endarterectomy in the Asymptomatic Carotid Atherosclerosis Study (ACAS) [J].
Baker, WH ;
Howard, VJ ;
Howard, G ;
Toole, JF .
STROKE, 2000, 31 (10) :2330-2334
[5]   The North American Symptomatic Carotid Endarterectomy Trial - Surgical results in 1415 patients [J].
Ferguson, GG ;
Eliasziw, M ;
Barr, HWK ;
Clagett, GP ;
Barnes, RW ;
Wallace, MC ;
Taylor, DW ;
Haynes, RB ;
Finan, JW ;
Hachinski, VC ;
Barnett, HJM .
STROKE, 1999, 30 (09) :1751-1758
[6]   High-risk carotid endarterectomy: Fact or fiction [J].
Gasparis, AP ;
Ricotta, L ;
Cuadra, SA ;
Char, DJ ;
Purtill, WA ;
Van Bemmelen, PS ;
Hines, GL ;
Giron, F ;
Ricotta, JJ .
JOURNAL OF VASCULAR SURGERY, 2003, 37 (01) :40-45
[7]   Update on the Carotid Revascularization Endarterectomy versus Stent Trial (CREST) protocol [J].
Hobson, RW .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2002, 194 (01) :S9-S14
[8]   Influence of NASCET/ACAS trial eligibility on outcome after carotid endarterectomy [J].
Lepore, MR ;
Sternbergh, WC ;
Salartash, K ;
Tonnessen, B ;
Money, SR .
JOURNAL OF VASCULAR SURGERY, 2001, 34 (04) :581-586
[9]   CAROTID ENDARTERECTOMY WITH AN OCCLUDED CONTRALATERAL CAROTID-ARTERY [J].
MCCARTHY, WJ ;
WANG, R ;
PEARCE, WH ;
FLINN, WR ;
YAO, JST .
AMERICAN JOURNAL OF SURGERY, 1993, 166 (02) :168-172
[10]   Preprocedural risk stratification: Identifying an appropriate population for carotid stenting [J].
Ouriel, K ;
Hertzer, NR ;
Beven, EG ;
O'Hara, P ;
Krajewski, LP ;
Clair, DG ;
Greenberg, RK ;
Sarac, TP ;
Olin, JW ;
Yadav, JS .
JOURNAL OF VASCULAR SURGERY, 2001, 33 (04) :728-732